Search Results - "Sun, Beicheng"
-
1
Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
Published in Nature reviews. Clinical oncology (01-05-2021)“…The immune system has crucial roles in cancer development and treatment. Whereas adaptive immunity can prevent or constrain cancer through immunosurveillance,…”
Get full text
Journal Article -
2
The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications
Published in Journal of hepatology (01-01-2020)“…Basic and clinical studies have demonstrated the efficacy of immunotherapy, a technical and conceptual breakthrough that has revolutionised cancer treatment…”
Get full text
Journal Article -
3
IL-33/ST2 signaling in liver transplantation
Published in Cellular & molecular immunology (01-03-2021)Get full text
Journal Article -
4
Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization
Published in Oncogene (13-02-2020)“…Recently, patients with advanced cancers have been benefited greatly from immune checkpoint blockade immunotherapy. However, immune checkpoint blockade is…”
Get full text
Journal Article -
5
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma
Published in Molecular cancer (18-11-2019)“…Dynamic N -methyladenosine (m A) modification was previously identified as a ubiquitous post-transcriptional regulation that affected mRNA homeostasis…”
Get full text
Journal Article -
6
VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway
Published in Oncogene (06-02-2020)“…Versican has been reported to participate in carcinogenesis in several malignant tumors. However, the accurate role of VersicanV1, a predominant isoform of…”
Get full text
Journal Article -
7
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion
Published in Nature communications (25-05-2017)“…Long noncoding RNAs play a pivotal role in T-helper cell development but little is known about their roles in Treg differentiation and functions during the…”
Get full text
Journal Article -
8
IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation
Published in The Journal of immunology (1950) (15-08-2013)“…Liver fibrosis is a severe, life-threatening clinical condition resulting from nonresolving hepatitis of different origins. IL-17A is critical in inflammation,…”
Get full text
Journal Article -
9
HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma
Published in Cellular physiology and biochemistry (01-01-2015)“…Background/Aims: The alterations of long non-coding RNAs (lncRNAs) are related to multiple diseases. They can be detected in plasma as biomarkers for the…”
Get full text
Journal Article -
10
LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway
Published in Oncotarget (15-12-2015)“…Hepatocellular carcinoma (HCC) is well known as the sixth most common malignant tumor and the third leading cause of cancer-related deaths globally. LINC00152…”
Get full text
Journal Article -
11
The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation
Published in Immunity (Cambridge, Mass.) (08-06-2021)“…Chronic inflammation plays a central role in hepatocellular carcinoma (HCC), but the contribution of hepatocytes to tumor-associated inflammation is not clear…”
Get full text
Journal Article -
12
Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma
Published in International journal of cancer (01-10-2015)“…The early detection of hepatocellular carcinoma (HCC) presents a challenge because of the lack of specific biomarkers. Serum/plasma microRNAs (miRNAs) can…”
Get full text
Journal Article -
13
Interleukin‐22 promotes human hepatocellular carcinoma by activation of STAT3
Published in Hepatology (Baltimore, Md.) (02-09-2011)“…Interleukin‐22 (IL‐22), one of the cytokines secreted by T helper 17 (Th17) cells, was recently reported to be a novel inflammation driver through STAT3…”
Get full text
Journal Article -
14
NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly
Published in Journal of hepatology (01-06-2020)“…Hepatomegaly can be triggered by insulin and insulin-unrelated etiologies. Insulin acts via AKT, but how other challenges cause hepatomegaly is unknown. Since…”
Get full text
Journal Article -
15
The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma
Published in Molecular carcinogenesis (01-02-2016)“…MEG3 as a tumor suppressor has been reported to be linked with pathogenesis of malignancies including hepatocellular carcinoma (HCC). However, the mechanism of…”
Get full text
Journal Article -
16
Ursodeoxycholic acid accelerates bile acid enterohepatic circulation
Published in British journal of pharmacology (01-08-2019)“…Background and Purpose Ursodeoxycholic acid (UDCA) is the first‐line treatment for primary biliary cholangitis, but its effects on the enterohepatic…”
Get full text
Journal Article -
17
NF-κB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia
Published in Cell death and differentiation (01-07-2020)“…Progression of chronic lymphocytic leukemia (CLL) and resistance to therapy are affected by tumor microenvironmental factors. One such factor is B-cell…”
Get full text
Journal Article -
18
CUG-binding protein 1 regulates HSC activation and liver fibrogenesis
Published in Nature communications (17-11-2016)“…Excessive activation of hepatic stellate cells (HSCs) is a key step in liver fibrogenesis. Here we report that CUG-binding protein 1 (CUGBP1) expression is…”
Get full text
Journal Article -
19
DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the Akt signaling pathway
Published in Journal of experimental & clinical cancer research (06-05-2024)“…Hepatocellular carcinoma (HCC) is a fatal malignancy with poor prognosis due to lack of effective clinical interference. DCAF1 plays a vital role in regulating…”
Get full text
Journal Article -
20
Down-Regulation of LncRNA DGCR5 Correlates with Poor Prognosis in Hepatocellular Carcinoma
Published in Cellular physiology and biochemistry (01-01-2016)“…Background/Aims: Long non-coding RNAs (lncRNAs) have been reported to play pivotal roles in multiple tumors and can act as tumor biomarkers. In this study, we…”
Get full text
Journal Article